Leadership Overview
WCG has 10 executives leading key functions including strategy, marketing, finance, technology, human resources, revenue partnerships, operations, legal, and president roles.
Driven by innovation, WCG measurably improves the quality and efficiency of clinical trials, facilitating the development of new treatments and therapies for patients worldwide.
Driven by innovation, WCG measurably improves the quality and efficiency of clinical trials, facilitating the development of new treatments and therapies for patients worldwide.
Leadership Roles at WCG
Sam Srivastava - Chief Executive Officer
Sam Srivastava, the Chief Executive Officer at WCG, directs the overarching strategy and vision for the organization. Srivastava guides WCG's mission to measurably improve the quality and efficiency of clinical trials, directly impacting the development of new treatments and therapies for patients. This leadership role involves aligning all departments toward achieving WCG's core objectives and expanding its market presence. Srivastava ensures that the company's operations consistently meet the high standards required in the biopharmaceutical and CRO sectors. The Chief Executive Officer's focus remains on driving innovation and fostering a culture of excellence across the entire enterprise. By setting strategic priorities, Srivastava enables WCG to effectively serve its clients and contribute significantly to medical advancements. The executive's leadership ensures robust growth and sustained operational effectiveness.
Anthony Doyle - Chief Financial Officer
Anthony Doyle, the Chief Financial Officer at WCG, manages the company's financial operations and strategic fiscal planning. Doyle oversees all financial activities, including budgeting, forecasting, financial reporting, and capital management, ensuring WCG's financial health and stability. This critical role involves providing financial insights to support executive decision-making and drive profitable growth. The Chief Financial Officer ensures compliance with all financial regulations and standards, maintaining WCG's integrity in the biopharmaceutical services industry. Anthony Doyle's expertise is vital in optimizing resource allocation and identifying opportunities for financial efficiency. The executive's leadership strengthens WCG's ability to invest in innovation and expand its services, directly contributing to the successful facilitation of new treatment development. Doyle's financial acumen underpins the company's long-term sustainability and market competitiveness.
Todd Joron - Co-Founder & Wcg Imaging President & Chief Operating Officer
Todd Joron, the Co-Founder & Wcg Imaging President & Chief Operating Officer at WCG, oversees the operational execution and strategic direction of WCG Imaging, alongside broader company operations. Joron ensures the efficient and effective delivery of WCG's services, focusing on optimizing processes that improve clinical trial quality and speed. This dual leadership role involves managing day-to-day operations and driving the growth and innovation within the WCG Imaging division. The Co-Founder & Wcg Imaging President & Chief Operating Officer is instrumental in translating WCG's mission into tangible operational outcomes, supporting the development of new therapies. Todd Joron's deep understanding of the company's founding principles and operational intricacies guides WCG's continuous improvement efforts. The executive's leadership ensures that WCG Imaging maintains its competitive edge and that overall company operations align with strategic goals for patient benefit.
Rbih Mansur - President
Rbih Mansur, the President at WCG, drives strategic initiatives and operational excellence across key business segments. Mansur focuses on enhancing WCG's capacity to measurably improve the quality and efficiency of clinical trials, thereby accelerating the development of new treatments. This leadership position involves overseeing specific divisions or regions, ensuring alignment with the company's overarching mission and strategic objectives. The President plays a crucial role in fostering collaboration and driving performance within their designated areas of responsibility. Rbih Mansur's leadership contributes directly to WCG's ability to serve biopharmaceutical companies and CROs effectively. The executive's focus on operational effectiveness and client satisfaction reinforces WCG's commitment to advancing patient care through innovative therapies. Mansur ensures that WCG's operational strategies support sustainable growth and market leadership.
Cynthia Carter - President, MI & I
Cynthia Carter, the President, MI & I at WCG, leads strategic growth and operational oversight for the Medical Information & Insights division. Carter directs initiatives aimed at enhancing the value and impact of medical information services within clinical trials, supporting the development of novel therapies. This executive role involves optimizing the integration of medical insights to improve trial quality and efficiency for biopharmaceutical clients and CROs. The President, MI & I ensures that WCG's medical information strategies align with industry best practices and regulatory requirements. Cynthia Carter's leadership focuses on leveraging data and expertise to provide actionable intelligence that accelerates therapeutic development. The executive's commitment to innovation drives the MI & I division's contribution to WCG's overall mission of improving patient outcomes. Carter fosters a culture of scientific rigor and strategic collaboration within the division.
Michael Passanante - Chief Marketing Officer
Michael Passanante, the Chief Marketing Officer at WCG, architects and executes comprehensive marketing strategies that elevate WCG's brand and market position. Passanante drives initiatives to communicate the company's value proposition in measurably improving clinical trial quality and efficiency to biopharmaceutical companies, CROs, and institutions. This leadership function involves overseeing all aspects of brand management, digital marketing, content creation, and public relations. The Chief Marketing Officer ensures consistent messaging across all channels, highlighting WCG's role in facilitating the development of new treatments. Michael Passanante's efforts directly support business development by generating qualified leads and strengthening client relationships. The executive's strategic vision enhances WCG's reputation as a leader in the clinical trial services sector, underscoring the company's commitment to patient well-being and therapeutic innovation.
Paul Mancinelli - Chief Technology Officer
Paul Mancinelli, the Chief Technology Officer at WCG, spearheads the company's technological vision and infrastructure development. Mancinelli directs the implementation and management of advanced technology solutions that enhance WCG's capabilities in improving clinical trial quality and efficiency. This leadership position involves overseeing all IT operations, cybersecurity, data management, and the integration of innovative digital tools. The Chief Technology Officer ensures that WCG's technological framework supports the rapid and effective development of new therapies. Paul Mancinelli's strategic technology investments enable WCG to maintain a competitive edge and deliver superior services to biopharmaceutical companies and CROs. The executive's focus on scalable and secure systems is paramount to protecting sensitive trial data and ensuring operational continuity. Mancinelli drives technological advancements that directly contribute to WCG's mission of accelerating patient access to novel treatments.
Elisa Calicchio - Chief Human Resources Officer
Elisa Calicchio, the Chief Human Resources Officer at WCG, leads the strategic direction of human capital management and organizational development. Calicchio oversees all HR functions, including talent acquisition, employee relations, compensation and benefits, and performance management, ensuring a robust and engaged workforce. This role is pivotal in cultivating a company culture that supports WCG's mission of improving clinical trial efficiency and fostering innovation. The Chief Human Resources Officer develops and implements programs that attract, retain, and develop top talent within the biopharmaceutical services sector. Elisa Calicchio's leadership ensures that WCG has the skilled personnel necessary to drive the development of new treatments and therapies. The executive's commitment to employee well-being and professional growth strengthens the company's operational capacity and its ability to meet client demands effectively. Calicchio champions initiatives that align human resources strategy with WCG's overall business objectives.
Antonio Castillo - Director, Chief Revenue Officer Partnerships
Antonio Castillo, the Director, Chief Revenue Officer Partnerships at WCG, drives strategic revenue growth through the cultivation and management of key partnerships. Castillo identifies and develops alliances with organizations that complement WCG's services, expanding market reach and revenue streams. This leadership function involves forging strong relationships with partners to ensure seamless collaboration and mutual benefit in facilitating clinical trials. The Director, Chief Revenue Officer Partnerships focuses on creating value-added solutions for clients by leveraging partner capabilities. Antonio Castillo's efforts directly contribute to WCG's ability to enhance the quality and efficiency of new treatment development. The executive's strategic approach to partnership management strengthens WCG's ecosystem and its capacity to serve a broader client base. Castillo ensures that partnership initiatives align with WCG's overall revenue objectives and its mission to accelerate patient access to therapies.
Jared Zane - Chief Legal Officer & Corporate Secretary
Jared Zane, the Chief Legal Officer & Corporate Secretary at WCG, provides expert legal counsel and oversees corporate governance. Zane manages all legal affairs, ensuring WCG operates in full compliance with relevant laws and regulations within the biopharmaceutical and clinical trial industries. This essential role involves advising the executive team and the Board of Directors on legal matters, risk mitigation, and corporate strategy. The Chief Legal Officer & Corporate Secretary safeguards WCG's interests and upholds the highest ethical standards. Jared Zane's legal acumen is critical in navigating the complex regulatory landscape associated with developing new treatments and therapies. The executive's diligence ensures that WCG's operations are legally sound, supporting the company's mission to improve trial quality and efficiency. Zane's responsibilities also include managing corporate records and facilitating board communications, ensuring robust governance.
Explore Leadership Teams in Business Services
Riverside Research operates as a not-for-profit scientific research organization dedicated to advancing technological innovation and solving complex challenges for government agencies and the broader public interest. The organization maintains a commitment to conducting rigorous, mission-critical research that addresses national priorities and contributes to scientific advancement across multiple disciplines. The organization has developed substantial expertise in applied research, systems analysis, and technical problem-solving. Riverside Research brings together multidisciplinary teams of scientists, engineers, and researchers who collaborate on projects spanning defense technology, information systems, advanced analytics, and strategic research initiatives. This collaborative approach enables the organization to tackle sophisticated technical challenges that require integration of multiple scientific and engineering domains. Riverside Research delivers comprehensive research and development services that translate scientific discovery into practical solutions. The organization's work encompasses fundamental research, applied development, testing and evaluation, and technical consulting. By maintaining independence as a not-for-profit entity, Riverside Research operates with flexibility to pursue research directions aligned with national needs while maintaining objectivity and scientific rigor in its investigations and analyses.
Company Leadership
EF
TF
KC
NEFCO, headquartered in Rochester, New Hampshire, and established in 1993, is a fire investigation company. Their services include fire scene and explosion investigation, scene inspection, litigation support, and evidence storage.
Company Leadership DE
CTI was founded in 1999 to provide therapeutic expertise to the pharmaceutical and biotechnology industry across a range of services. They have experienced consistent and significant growth from a US-based organization to a multi-national corporation.
Company Leadership JB
PD
MM
Founded in 1940, Department of Energy - Argonne National Laboratory is a science and engineering research national laboratory that specializes in energy, global security, and energy systems. Department of Energy - Argonne National Laboratory is located in Illinois.
Company Leadership DR
PG
MS
DR
Frequently Asked Questions Regarding WCG Top Executives and Leadership Team
